Araclon Biotech


Contact information

Araclon Biotech, SL
Ian Sherriff (Asuntos Internacionales) / Irene San José (Coordinadora de áreas)
Paseo de Sagasta nº 17, 2º Izda.
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • In vitro diagnostics
      • Vaccines
    • Therapeutic areas
      • Central nervous system

Araclon Biotech is a company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, currently focusing on Alzheimer's disease.

Products and services

At present, Araclon is working on four different projects:

The first of these focuses on the diagnosis of Alzheimer's disease (with detection kits for beta-amyloid 40 and 42 proteins in blood already patented and a kit for AB17 patent pending).

The second is centred on Alzheimer's therapy (immunotherapy based).

The third is an emerging project, which attempts to respond to the challenge of predicting Alzheimer's disease in totally asymptomatic individuals.

And finally, a project related to the development of a therapy for the Parkinson's disease